nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—Hypoxemia—Zidovudine—acquired immunodeficiency syndrome	0.0703	0.0826	CcSEcCtD
Mivacurium—Hypoxemia—Lamivudine—acquired immunodeficiency syndrome	0.0502	0.059	CcSEcCtD
Mivacurium—Hypoxia—Zidovudine—acquired immunodeficiency syndrome	0.0222	0.0261	CcSEcCtD
Mivacurium—Hypoxia—Ritonavir—acquired immunodeficiency syndrome	0.0173	0.0203	CcSEcCtD
Mivacurium—Hypoxia—Lamivudine—acquired immunodeficiency syndrome	0.0158	0.0186	CcSEcCtD
Mivacurium—Wheezing—Abacavir—acquired immunodeficiency syndrome	0.0155	0.0183	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Didanosine—acquired immunodeficiency syndrome	0.014	0.0165	CcSEcCtD
Mivacurium—Wheezing—Zidovudine—acquired immunodeficiency syndrome	0.0137	0.0161	CcSEcCtD
Mivacurium—Phlebitis—Zidovudine—acquired immunodeficiency syndrome	0.0119	0.014	CcSEcCtD
Mivacurium—CHRNA1—lymphoid tissue—acquired immunodeficiency syndrome	0.0105	0.0702	CbGeAlD
Mivacurium—CHRND—lung—acquired immunodeficiency syndrome	0.0104	0.0694	CbGeAlD
Mivacurium—Bronchospasm—Nelfinavir—acquired immunodeficiency syndrome	0.01	0.0118	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Indinavir—acquired immunodeficiency syndrome	0.00984	0.0116	CcSEcCtD
Mivacurium—Wheezing—Lamivudine—acquired immunodeficiency syndrome	0.00978	0.0115	CcSEcCtD
Mivacurium—Cardiac disorder—Amprenavir—acquired immunodeficiency syndrome	0.00956	0.0112	CcSEcCtD
Mivacurium—Phlebitis—Ritonavir—acquired immunodeficiency syndrome	0.00924	0.0109	CcSEcCtD
Mivacurium—BCHE—blood plasma—acquired immunodeficiency syndrome	0.00886	0.0593	CbGeAlD
Mivacurium—Phlebitis—Lamivudine—acquired immunodeficiency syndrome	0.00848	0.00997	CcSEcCtD
Mivacurium—CHRNA2—blood—acquired immunodeficiency syndrome	0.00819	0.0548	CbGeAlD
Mivacurium—Immune system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00762	0.00896	CcSEcCtD
Mivacurium—CHRNB1—blood—acquired immunodeficiency syndrome	0.00762	0.051	CbGeAlD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Amprenavir—acquired immunodeficiency syndrome	0.00758	0.00891	CcSEcCtD
Mivacurium—Angiopathy—Nelfinavir—acquired immunodeficiency syndrome	0.00742	0.00872	CcSEcCtD
Mivacurium—Immune system disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00738	0.00868	CcSEcCtD
Mivacurium—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.00735	0.00864	CcSEcCtD
Mivacurium—CHRNB1—spinal cord—acquired immunodeficiency syndrome	0.00734	0.0491	CbGeAlD
Mivacurium—Immune system disorder—Abacavir—acquired immunodeficiency syndrome	0.00725	0.00852	CcSEcCtD
Mivacurium—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.00711	0.00837	CcSEcCtD
Mivacurium—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.0071	0.00835	CcSEcCtD
Mivacurium—CHRNB1—vagina—acquired immunodeficiency syndrome	0.00706	0.0473	CbGeAlD
Mivacurium—Muscle spasms—Nelfinavir—acquired immunodeficiency syndrome	0.00684	0.00804	CcSEcCtD
Mivacurium—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00667	0.00784	CcSEcCtD
Mivacurium—CHRNA2—nervous system—acquired immunodeficiency syndrome	0.00665	0.0445	CbGeAlD
Mivacurium—Cardiac disorder—Zidovudine—acquired immunodeficiency syndrome	0.00657	0.00773	CcSEcCtD
Mivacurium—CHRNA2—central nervous system—acquired immunodeficiency syndrome	0.0064	0.0428	CbGeAlD
Mivacurium—Mediastinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00638	0.0075	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.00621	0.0073	CcSEcCtD
Mivacurium—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.00617	0.00725	CcSEcCtD
Mivacurium—CHRNA1—brain—acquired immunodeficiency syndrome	0.00612	0.041	CbGeAlD
Mivacurium—Flushing—Indinavir—acquired immunodeficiency syndrome	0.00611	0.00719	CcSEcCtD
Mivacurium—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.00606	0.00713	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.00602	0.00707	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.006	0.00705	CcSEcCtD
Mivacurium—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.006	0.00705	CcSEcCtD
Mivacurium—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.00595	0.00699	CcSEcCtD
Mivacurium—Muscle spasms—Zidovudine—acquired immunodeficiency syndrome	0.00593	0.00697	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.00591	0.00695	CcSEcCtD
Mivacurium—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.00582	0.00685	CcSEcCtD
Mivacurium—Cardiac disorder—Efavirenz—acquired immunodeficiency syndrome	0.00578	0.00679	CcSEcCtD
Mivacurium—Flushing—Efavirenz—acquired immunodeficiency syndrome	0.00578	0.00679	CcSEcCtD
Mivacurium—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.0057	0.0067	CcSEcCtD
Mivacurium—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.00565	0.00664	CcSEcCtD
Mivacurium—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00564	0.00663	CcSEcCtD
Mivacurium—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.00562	0.00661	CcSEcCtD
Mivacurium—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00562	0.00661	CcSEcCtD
Mivacurium—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00561	0.00659	CcSEcCtD
Mivacurium—Arrhythmia—Efavirenz—acquired immunodeficiency syndrome	0.00556	0.00654	CcSEcCtD
Mivacurium—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00554	0.00651	CcSEcCtD
Mivacurium—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.00551	0.00648	CcSEcCtD
Mivacurium—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00542	0.00637	CcSEcCtD
Mivacurium—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00533	0.00627	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00521	0.00613	CcSEcCtD
Mivacurium—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00518	0.00609	CcSEcCtD
Mivacurium—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.00511	0.00601	CcSEcCtD
Mivacurium—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.00511	0.00601	CcSEcCtD
Mivacurium—CHRNA2—brain—acquired immunodeficiency syndrome	0.00508	0.034	CbGeAlD
Mivacurium—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00503	0.00592	CcSEcCtD
Mivacurium—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.005	0.00587	CcSEcCtD
Mivacurium—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.00498	0.00586	CcSEcCtD
Mivacurium—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00497	0.00585	CcSEcCtD
Mivacurium—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00496	0.00583	CcSEcCtD
Mivacurium—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.00492	0.00578	CcSEcCtD
Mivacurium—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00489	0.00575	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00485	0.0057	CcSEcCtD
Mivacurium—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.00481	0.00565	CcSEcCtD
Mivacurium—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00479	0.00563	CcSEcCtD
Mivacurium—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00478	0.00562	CcSEcCtD
Mivacurium—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00476	0.0056	CcSEcCtD
Mivacurium—CHRNB1—brain—acquired immunodeficiency syndrome	0.00473	0.0316	CbGeAlD
Mivacurium—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00468	0.0055	CcSEcCtD
Mivacurium—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00461	0.00542	CcSEcCtD
Mivacurium—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00461	0.00542	CcSEcCtD
Mivacurium—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00461	0.00542	CcSEcCtD
Mivacurium—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.00461	0.00542	CcSEcCtD
Mivacurium—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00461	0.00542	CcSEcCtD
Mivacurium—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.0046	0.00541	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00458	0.00538	CcSEcCtD
Mivacurium—CHRNB1—lymph node—acquired immunodeficiency syndrome	0.00457	0.0306	CbGeAlD
Mivacurium—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00457	0.00537	CcSEcCtD
Mivacurium—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00456	0.00536	CcSEcCtD
Mivacurium—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00455	0.00534	CcSEcCtD
Mivacurium—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00453	0.00533	CcSEcCtD
Mivacurium—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.00444	0.00521	CcSEcCtD
Mivacurium—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.0044	0.00517	CcSEcCtD
Mivacurium—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00431	0.00507	CcSEcCtD
Mivacurium—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00429	0.00505	CcSEcCtD
Mivacurium—BCHE—skin of body—acquired immunodeficiency syndrome	0.00426	0.0285	CbGeAlD
Mivacurium—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00423	0.00497	CcSEcCtD
Mivacurium—Rash—Didanosine—acquired immunodeficiency syndrome	0.0042	0.00494	CcSEcCtD
Mivacurium—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.0042	0.00494	CcSEcCtD
Mivacurium—CHRM3—digestive system—acquired immunodeficiency syndrome	0.00418	0.0279	CbGeAlD
Mivacurium—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00413	0.00485	CcSEcCtD
Mivacurium—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00411	0.00483	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00405	0.00476	CcSEcCtD
Mivacurium—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.004	0.0047	CcSEcCtD
Mivacurium—CHRM2—nervous system—acquired immunodeficiency syndrome	0.00396	0.0265	CbGeAlD
Mivacurium—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00395	0.00465	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.0039	0.00459	CcSEcCtD
Mivacurium—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00384	0.00451	CcSEcCtD
Mivacurium—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00383	0.0045	CcSEcCtD
Mivacurium—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00382	0.00449	CcSEcCtD
Mivacurium—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.00382	0.0255	CbGeAlD
Mivacurium—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.0038	0.00447	CcSEcCtD
Mivacurium—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00378	0.00444	CcSEcCtD
Mivacurium—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00378	0.00444	CcSEcCtD
Mivacurium—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00377	0.00443	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00372	0.00437	CcSEcCtD
Mivacurium—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00372	0.00437	CcSEcCtD
Mivacurium—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00366	0.0043	CcSEcCtD
Mivacurium—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00366	0.0043	CcSEcCtD
Mivacurium—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00366	0.0043	CcSEcCtD
Mivacurium—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00366	0.0043	CcSEcCtD
Mivacurium—Rash—Stavudine—acquired immunodeficiency syndrome	0.00365	0.00429	CcSEcCtD
Mivacurium—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00365	0.00429	CcSEcCtD
Mivacurium—Rash—Abacavir—acquired immunodeficiency syndrome	0.0036	0.00423	CcSEcCtD
Mivacurium—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00359	0.00422	CcSEcCtD
Mivacurium—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00359	0.00422	CcSEcCtD
Mivacurium—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00352	0.00414	CcSEcCtD
Mivacurium—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00351	0.00413	CcSEcCtD
Mivacurium—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00349	0.0041	CcSEcCtD
Mivacurium—BCHE—digestive system—acquired immunodeficiency syndrome	0.00341	0.0228	CbGeAlD
Mivacurium—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00336	0.00395	CcSEcCtD
Mivacurium—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00336	0.00395	CcSEcCtD
Mivacurium—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00333	0.00391	CcSEcCtD
Mivacurium—BCHE—blood—acquired immunodeficiency syndrome	0.00325	0.0217	CbGeAlD
Mivacurium—CHRM3—nervous system—acquired immunodeficiency syndrome	0.00323	0.0216	CbGeAlD
Mivacurium—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00317	0.00373	CcSEcCtD
Mivacurium—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00317	0.00373	CcSEcCtD
Mivacurium—BCHE—bone marrow—acquired immunodeficiency syndrome	0.00314	0.021	CbGeAlD
Mivacurium—BCHE—spinal cord—acquired immunodeficiency syndrome	0.00313	0.0209	CbGeAlD
Mivacurium—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.00311	0.0208	CbGeAlD
Mivacurium—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00311	0.00365	CcSEcCtD
Mivacurium—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00309	0.00364	CcSEcCtD
Mivacurium—CHRM2—brain—acquired immunodeficiency syndrome	0.00303	0.0203	CbGeAlD
Mivacurium—BCHE—vagina—acquired immunodeficiency syndrome	0.00301	0.0201	CbGeAlD
Mivacurium—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00299	0.00352	CcSEcCtD
Mivacurium—Rash—Indinavir—acquired immunodeficiency syndrome	0.00295	0.00347	CcSEcCtD
Mivacurium—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00295	0.00347	CcSEcCtD
Mivacurium—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00292	0.00344	CcSEcCtD
Mivacurium—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00285	0.00335	CcSEcCtD
Mivacurium—BCHE—lung—acquired immunodeficiency syndrome	0.00285	0.019	CbGeAlD
Mivacurium—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.0028	0.00329	CcSEcCtD
Mivacurium—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00279	0.00328	CcSEcCtD
Mivacurium—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00279	0.00327	CcSEcCtD
Mivacurium—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00267	0.00314	CcSEcCtD
Mivacurium—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00266	0.00313	CcSEcCtD
Mivacurium—BCHE—nervous system—acquired immunodeficiency syndrome	0.00264	0.0176	CbGeAlD
Mivacurium—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00259	0.00304	CcSEcCtD
Mivacurium—BCHE—central nervous system—acquired immunodeficiency syndrome	0.00254	0.017	CbGeAlD
Mivacurium—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00249	0.00293	CcSEcCtD
Mivacurium—CHRM3—brain—acquired immunodeficiency syndrome	0.00247	0.0165	CbGeAlD
Mivacurium—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00247	0.0029	CcSEcCtD
Mivacurium—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00246	0.0029	CcSEcCtD
Mivacurium—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00238	0.00279	CcSEcCtD
Mivacurium—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00237	0.00279	CcSEcCtD
Mivacurium—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00237	0.00279	CcSEcCtD
Mivacurium—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00226	0.00266	CcSEcCtD
Mivacurium—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00226	0.00266	CcSEcCtD
Mivacurium—BCHE—brain—acquired immunodeficiency syndrome	0.00201	0.0135	CbGeAlD
Mivacurium—BCHE—lymph node—acquired immunodeficiency syndrome	0.00195	0.013	CbGeAlD
